Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04138927 |
|---|---|
| Brief Title: | A Phase 3 Open Label Extension Study of Fostamatinib Disodium in the Treatment of Warm Antibody Autoimmune Hemolytic Anemia |
| First Submitted : | October 23, 2019 |
| First Submitted that Met QC Criteria : | October 23, 2019 |
| First Posted : | October 25, 2019 |
| Last Update Submitted that Met QC Criteria : | March 2, 2022 |
| Last Update Posted : | March 17, 2022 |